Rep. Bruce Westerman Sells UnitedHealth Group Incorporated (NYSE:UNH) Stock

Representative Bruce Westerman (R-Arkansas) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on April 21st. The trade occurred in the Representative's "FISHER IRA" account.

Representative Bruce Westerman also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Tokyo Electron OTCMKTS: TOELY on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Anheuser-Busch InBev SA/NV NYSE: BUD on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Edwards Lifesciences NYSE: EW on 4/21/2025.
• Sold $1,001 - $15,000 in shares of HSBC NYSE: HSBC on 4/21/2025.
• Sold $15,001 - $50,000 in shares of Apple NASDAQ: AAPL on 4/21/2025.
• Sold $1,001 - $15,000 in shares of DSV A/S OTCMKTS: DSDVY on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Walmart NYSE: WMT on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Bank of America NYSE: BAC on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Thermo Fisher Scientific NYSE: TMO on 4/21/2025.

UnitedHealth Group Stock Up 6.2%

UNH traded up $16.89 on Friday, hitting $291.24. 70,463,502 shares of the company were exchanged, compared to its average volume of 5,875,758. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a market cap of $264.20 billion, a PE ratio of 18.79, a PEG ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock's fifty day moving average is $470.82 and its 200-day moving average is $513.60.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the company posted $6.91 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 2.88%. UnitedHealth Group's payout ratio is presently 35.18%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Raymond James downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday. Hsbc Global Res downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 22nd. JPMorgan Chase & Co. decreased their target price on UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a research report on Thursday. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Finally, KeyCorp decreased their target price on UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating on the stock in a research report on Wednesday. Six investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average price target of $486.00.

Institutional Investors Weigh In On UnitedHealth Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in UNH. Norges Bank bought a new stake in UnitedHealth Group during the fourth quarter worth $6,375,744,000. GAMMA Investing LLC lifted its stake in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after purchasing an additional 8,280,404 shares during the last quarter. Nuveen LLC bought a new position in shares of UnitedHealth Group in the 1st quarter valued at $3,846,764,000. Vanguard Group Inc. lifted its stake in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after acquiring an additional 5,583,343 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $1,914,740,000. 87.86% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 109,408 shares of company stock worth $31,607,768. Insiders own 0.33% of the company's stock.

About Representative Westerman

Bruce Westerman (Republican Party) is a member of the U.S. House, representing Arkansas' 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027. Westerman (Republican Party) is running for re-election to the U.S. House to represent Arkansas' 4th Congressional District. He declared candidacy for the 2026 election. Westerman earned his BSBAGE in biological and agricultural engineering from the University of Arkansas in 1990 and his MF in forestry from Yale University in 2001. His professional experience includes working as a plant engineer for Riceland Foods and an engineer/forester for Mid-South Engineering Company.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.